XENE
Xenon Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$39.75
−30.69%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-32.9%
Return on equity
-31.6%
Return on assets
-35.4%
Return on invested capital
0.00x
Asset turnover
-$337.5M
Cash from operations
$9.61
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026